BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11808319)

  • 1. [Pharmacotherapy for the treatment of Alzheimer's disease--the present state and the development in the future].
    Yamaguchi N; Okada N; Sugiyama T
    Nihon Rinsho; 2002 Jan; 60(1):107-11. PubMed ID: 11808319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: current knowledge, management and research.
    Gauthier S; Panisset M; Nalbantoglu J; Poirier J
    CMAJ; 1997 Oct; 157(8):1047-52. PubMed ID: 9347775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alzheimer's disease--the molecular biological mechanism and the therapeutic drug design].
    Nabeshima T; Takeda M
    Nihon Yakurigaku Zasshi; 1996 Sep; 108(3):132-4. PubMed ID: 9091440
    [No Abstract]   [Full Text] [Related]  

  • 5. [The mechanism of A beta production and its inhibition as a therapeutic strategy for the prevention of Alzheimer's disease].
    Iwatsubo T
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):30P-33P. PubMed ID: 12491772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Production and catabolism of amyloid peptides in Alzheimer's disease].
    Checler F
    Therapie; 2010; 65(5):409-14. PubMed ID: 21144475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease: genesis of amyloid.
    Beyreuther K; Multhaup G; Masters CL
    Ciba Found Symp; 1996; 199():119-27; discussion 127-31. PubMed ID: 8915607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [beta-amyloid cascade: current status and future directions].
    Iwatsubo T
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1228-30. PubMed ID: 11464463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?
    Saxena U
    Expert Opin Ther Targets; 2010 Dec; 14(12):1273-7. PubMed ID: 21058918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of drugs for Alzheimer's disease.
    Sun X; Jin L; Ling P
    Drug Discov Ther; 2012 Dec; 6(6):285-90. PubMed ID: 23337815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-secretase inhibition for the treatment of Alzheimer's disease--promise and challenge.
    Citron M
    Trends Pharmacol Sci; 2004 Feb; 25(2):92-7. PubMed ID: 15102495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease: aging, insomnia and epigenetics.
    Wu TY; Chen CP; Jinn TR
    Taiwan J Obstet Gynecol; 2010 Dec; 49(4):468-72. PubMed ID: 21199749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice.
    Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B
    J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretases as therapeutic targets for Alzheimer's disease.
    Woo HN; Baik SH; Park JS; Gwon AR; Yang S; Yun YK; Jo DG
    Biochem Biophys Res Commun; 2011 Jan; 404(1):10-5. PubMed ID: 21130746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research progress on Alzheimer's disease: pathogenesis and medical therapy].
    Sheng SL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):101-3. PubMed ID: 15171541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological characteristics of amyloid precursor protein and Alzheimer's disease].
    Fukatsu R; Tsuzuki K; Takamaru Y; Hayashi Y; Sasaki N; Yoshida T; Midorikawa Y; Fujii N; Takahata N
    Rinsho Byori; 1996 Mar; 44(3):213-24. PubMed ID: 8857163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-modifying approaches to Alzheimer's disease: challenges and opportunities-Lessons from donepezil therapy.
    Sabbagh MN; Richardson S; Relkin N
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S109-18. PubMed ID: 18631986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease.
    Grimm MO; Kuchenbecker J; Rothhaar TL; Grösgen S; Hundsdörfer B; Burg VK; Friess P; Müller U; Grimm HS; Riemenschneider M; Hartmann T
    J Neurochem; 2011 Mar; 116(5):916-25. PubMed ID: 21214572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in Alzheimer's disease drug discovery: an update.
    Williams M
    Curr Opin Investig Drugs; 2009 Jan; 10(1):23-34. PubMed ID: 19127484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.